Kura Oncology Inc. (KURA)
NASDAQ: KURA
· Real-Time Price · USD
7.37
0.77 (11.67%)
At close: Aug 15, 2025, 3:14 PM
Kura Oncology Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 83.28M | 67.99M | 53.88M | 1.27M | 1.27M | 1.27M | 1.27M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 636K | 614K | 848K | 858K | 866K | 877K | 849K | 841K | 625K | 595K | 566K | 526K | 686K | 627K | 558K | 392K | 232K | 108K |
Gross Profit | 82.64M | 67.38M | 53.03M | 412K | 404K | 393K | 421K | -841K | -625K | -595K | -566K | -526K | -686K | -627K | -558K | -392K | -232K | -108K |
Operating Income | -219.71M | -203.44M | -193.19M | -217.5M | -200.09M | -183.69M | -166.01M | -154.61M | -148.73M | -143.5M | -139.18M | -136.56M | -133.64M | -132.52M | -130.96M | -124.55M | -115.07M | -102.59M |
Interest Income | 26.36M | 25.4M | 22.85M | 21.56M | 19.94M | 17.19M | 14.72M | 12.62M | 9.44M | 6.79M | 4.25M | 2.28M | 1.5M | 1.23M | 1.21M | 1.22M | 1.48M | 2.02M |
Pretax Income | -194.93M | -179.64M | -171.97M | -197.55M | -181.75M | -168.09M | -152.63M | -142.96M | -139.86M | -137.46M | -135.84M | -135.47M | -133.33M | -132.22M | -130.47M | -123.88M | -114.28M | -101.11M |
Net Income | -197.17M | -181.89M | -173.98M | -197.55M | -181.75M | -168.09M | -149.56M | -140.12M | -137.02M | -135.18M | -136.96M | -136.36M | -134.22M | -132.55M | -130.47M | -123.88M | -114.28M | -101.11M |
Selling & General & Admin | 90.25M | 81.56M | 76.67M | 66.62M | 61.59M | 56.93M | 50.35M | 48.83M | 47.3M | 46.56M | 47.05M | 46.65M | 46.34M | 47.83M | 46.54M | 43.26M | 39.55M | 34.45M |
Research & Development | 212.73M | 189.67M | 169.97M | 150.23M | 137.86M | 126.31M | 115.23M | 105.37M | 101.02M | 97.09M | 92.81M | 91.1M | 88.49M | 85.31M | 84.72M | 81.29M | 75.52M | 68.15M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 295K | 295K | 295K | 303K | 181K | 193K | 205K |
Operating Expenses | 302.98M | 271.23M | 246.64M | 216.85M | 199.44M | 183.24M | 165.59M | 154.2M | 148.32M | 143.65M | 139.87M | 137.75M | 134.83M | 133.14M | 131.26M | 124.55M | 115.07M | 102.59M |
Interest Expense | 1.59M | 1.6M | 1.62M | 1.61M | 1.6M | 1.58M | 1.55M | 1.38M | 980K | 593K | 229K | n/a | n/a | 306K | 414K | 558K | 704K | 542K |
Selling & Marketing Expenses | n/a | -202K | -436K | -650K | -650K | -448K | -214K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 302.98M | 271.43M | 247.08M | 217.5M | 200.09M | 183.69M | 165.8M | 154.2M | 148.32M | 143.65M | 139.87M | 137.75M | 134.83M | 133.14M | 131.26M | 124.55M | 115.07M | 102.59M |
Income Tax Expense | 2.24M | 2.24M | 2.02M | n/a | n/a | -213K | -3.28M | -3.05M | -3.05M | -2.27M | 1.12M | 727K | 1.04M | 764K | 551K | 609K | 456K | 166K |
Shares Outstanding (Basic) | 87.59M | 87.42M | 87.14M | 86.95M | 86.64M | 83.91M | 77.34M | 77.24M | 69.8M | 68.4M | 67.78M | 66.89M | 66.67M | 66.61M | 66.55M | 66.35M | 66.28M | 66.22M |
Shares Outstanding (Diluted) | 87.59M | 87.42M | 87.14M | 86.95M | 86.64M | 83.91M | 77.34M | 77.24M | 69.8M | 68.4M | 67.78M | 66.89M | 66.67M | 66.61M | 66.55M | 66.35M | 66.28M | 66.22M |
EPS (Basic) | -2.26 | -2.1 | -2.03 | -2.36 | -2.23 | -2.17 | -2.03 | -1.97 | -2 | -2 | -2.04 | -2.04 | -2.01 | -1.99 | -1.96 | -1.92 | -1.84 | -1.73 |
EPS (Diluted) | -2.26 | -2.1 | -2.03 | -2.36 | -2.23 | -2.17 | -2.03 | -1.97 | -2 | -2 | -2.04 | -2.04 | -2.01 | -1.99 | -1.96 | -1.92 | -1.84 | -1.73 |
EBITDA | -207.74M | -185.31M | -169.5M | -195.08M | -179.28M | -165.63M | -150.23M | -140.73M | -138.06M | -136.07M | -134.85M | -134.75M | -132.65M | -131.5M | -129.71M | -123.04M | -113.38M | -100.27M |
EBIT | -194.1M | -178.8M | -170.35M | -195.94M | -180.15M | -166.5M | -151.08M | -141.57M | -138.88M | -136.86M | -135.61M | -135.47M | -133.33M | -131.92M | -130.05M | -123.32M | -113.58M | -100.57M |
Depreciation & Amortization | -6.48M | -6.5M | 848K | 858K | 866K | 877K | 849K | 841K | 818K | 788K | 759K | 719K | 686K | 627K | 558K | 500K | 414K | 296K |